Skip Navigation

VAERS Bibliography - September 2004

  1. Assessment of the Effectiveness of the 2003-04 Influenza Vaccine Among Children and Adults--Colorado, 2003.   MMWR Morb.Mortal.Wkly.Rep.  53 (31): 707-710; August 13, 2004.

  2. The National Immunization Strategy.   Can.Commun.Dis.Rep.  30 (15): 136-138; August 1, 2004.

  3. [Research Shows Little Engagement of Doctors in Encouraging Influenza Immunization].   Rev.Saude Publica.  38 (4): 607-608; August, 2004.

  4. Aaby, P.; Rodrigues, A.; Biai, S.; Martins, C.; Veirum, J. E.; Benn, C. S.; Jensen, H.  Oral Polio Vaccination and Low Case Fatality at the Paediatric Ward in Bissau, Guinea-Bissau.   Vaccine.  22 (23-24): 3014-3017; August 13, 2004.

  5. Abel, R. L.; McGaha, P.; Young, R.; Bing, M.; Foran, T.; Oaks, B.  Understanding Differences in Influenza Immunization Rates: a Survey of African-American and Caucasian Medicare Beneficiaries in Texas.   J.Health Hum.Serv.Adm.  26 (2): 174-198; 2003.

  6. Ahmad, K.  Polio Spreads to Western Darfur.    Lancet Neurol.  3 (8): 450; August, 2004.

  7. Armstrong, B. G.; Mangtani, P.; Fletcher, A.; Kovats, S.; McMichael, A.; Pattenden, S.; Wilkinson, P.  Effect of Influenza Vaccination on Excess Deaths Occurring During Periods of High Circulation of Influenza: Cohort Study in Elderly People.   BMJ.  August 15, 2004. [Epub ahead of print].

  8. Arshi, S.; Sadeghi-Bazargani, H.; Ojaghi, H.; Savadi-Oskouei, D.; Hekmat, S.; Jastan, M.; Majidpour, A.; Shahizareh, F.  The First Rapid Onset Optic Neuritis After Measles-Rubella Vaccination: Case Report.   Vaccine.  22 (25-26): 3240-3242; September 3, 2004.

  9. Ashraf, H.  WHO Regroups Efforts Against Polio Resurgence in Africa.   Lancet Infect.Dis.  4 (8): 477; August, 2004.

  10. Bakir, M.; El Khadir, A.; Devadas, K.; Farrukh, A. S.; Uduman, S. A.  Haemophilus Influenzae Type b Diseases in Children: a Pre-Vaccination Study.   East Mediterr.Health J.  7 (4-5): 597-603; July, 2001.

  11. Ball, F.; Britton, T.; Lyne, O.  Stochastic Multitype Epidemics in a Community of Households: Estimation and Form of Optimal Vaccination Schemes.   Math.Biosci.  191 (1): 19-40; September, 2004.

  12. Banerjee, S.; Nandyala, A.; Podili, R.; Katoch, V. M.; Murthy, K. J.; Hasnain, S. E.  Mycobacterium Tuberculosis (Mtb) Isocitrate Dehydrogenases Show Strong B Cell Response and Distinguish Vaccinated Controls From TB Patients.   Proc.Natl.Acad.Sci.U.S.A.  101 (34): 12652-12657; August 24, 2004.

  13. Bauch, C. T.; Earn, D. J.  Vaccination and the Theory of Games.   Proc.Natl.Acad.Sci.U.S.A.  101 (36): 13391-13394; September 7, 2004.

  14. Bedford, H.  Measles and the Importance of Maintaining Vaccination Levels.   Nurs.Times.  100 (26): 52-55; June 29, 2004.

  15. Berg, A. T.  Seizure Risk With Vaccination.   Epilepsy Curr.  2 (1): 15-16; January, 2002.

  16. Beutels, P.  Potential Conflicts of Interest in Vaccine Economics Research: a Commentary With a Case Study of Pneumococcal Conjugate Vaccination.   Vaccine.  22 (25-26): 3312-3322; September 3, 2004.

  17. Cilla, G.; Dorronsoro, M.; Saenz-Dominguez, J. R.; Serrano, E.; Perez-Trallero, E.  Increase of Immunity to Rubella and Interruption of Rubella Transmission in Gipuzkoa (Basque Country, Spain) After an Enhanced Vaccination Programme.   Epidemiol.Infect.  132 (4): 685-692; August, 2004.

  18. Colgrove, J.  The Power of Persuasion: Diphtheria Immunization, Advertising, and the Rise of Health Education.   Public Health Rep.  119 (5): 506-509; September, 2004.

  19. Degefie, T.  Tuberculous Meningitis in a District Hospital From Southern Ethiopia.   Ethiop.Med.J.  41 (4): 311-318; October, 2003.

  20. Edelman, K. J.; He, Q.; Makinen, J. P.; Haanpera, M. S.; Nguyen Tran, Minh N.; Schuerman, L.; Wolter, J.; Mertsola, J. A.  Pertussis-Specific Cell-Mediated and Humoral Immunity in Adolescents 3 Years After Booster Immunization With Acellular Pertussis Vaccine.   Clin.Infect.Dis.  39 (2): 179-185; July 15, 2004.

  21. Fitch, P.; Racine, A.  Parental Beliefs About Vaccination Among an Ethnically Diverse Inner-City Population.   J.Natl.Med.Assoc.  96 (8): 1047-1050; August, 2004.

  22. Foster, B. S.; Agahigian, D. D.  Central Serous Chorioretinopathy Associated With Anthrax Vaccination.   Retina.  24 (4): 624-625; August, 2004.

  23. Friman, V.; Hahn-Zoric, M.; Bjorkander, J.; Oxelius, V. A.; Hanson, L. A.  Aberrant IgG2 Antibody Response to Neisseria Meningitidis Polysaccharide A After Vaccination in Frequently Infected Compared to Healthy IgA-Deficient Individuals.   Scand.J.Immunol.  60 (3): 292-298; September, 2004.

  24. Glass, K.; Kappey, K.; Grenfell, B. T.  The Effect of Heterogeneity in Measles Vaccination on Population Immunity.   Epidemiol.Infect.  132 (4): 675-683; August, 2004.

  25. Goel, N. K.; Swami, H. M.  Cold Chain System in Chandigarh During Intensified Pulse Polio Immunization 2001-2002.   Indian Pediatr.  41 (7): 750-751; July, 2004.

  26. Guy, B.; Chanthavanich, P.; Gimenez, S.; Sirivichayakul, C.; Sabchareon, A.; Begue, S.; Yoksan, S.; Luxemburger, C.; Lang, J.  Evaluation by Flow Cytometry of Antibody-Dependent Enhancement (ADE) of Dengue Infection by Sera From Thai Children Immunized With a Live-Attenuated Tetravalent Dengue Vaccine.   Vaccine.  22 (27-28): 3563-3574; September 9, 2004.

  27. Hoover, D. R.; Sambamoorthi, U.; Crystal, S.  Characteristics of Community Dwelling Elderly Not Vaccinated for Pneumococcus in 1998 and 2001.   Prev.Med.  39 (3): 517-527; September, 2004.

  28. Hviid, A.; Stellfeld, M.; Andersen, P. H.; Wohlfahrt, J.; Melbye, M.  Impact of Routine Vaccination With a Pertussis Toxoid Vaccine in Denmark.   Vaccine.  22 (27-28): 3530-3534; September 9, 2004.

  29. Ismail, A. A.; Harris, S. L.; Granoff, D. M.  Serum Group a Anticapsular Antibodies in a Sudanese Population Immunized With Meningococcal Polysaccharide Vaccine During a Group A Epidemic.   Pediatr.Infect.Dis.J.  23 (8): 748-755; August, 2004.

  30. Khalil, M. K.; Al Mazrou, Y. Y.; Al Jeffri, M.; Al Ghamdy, Y. S.  Measles Immunization in Saudi Arabia: the Need for Change.   East Mediterr.Health J.  7 (4-5): 829-834; July, 2001.

  31. Kohl, K. S.; Marcy, S. M.; Blum, M.; Connell, Jones M.; Dagan, R.; Hansen, J.; Nalin, D.; Rothstein, E.  Fever After Immunization: Current Concepts and Improved Future Scientific Understanding.   Clin.Infect.Dis.  39 (3): 389-394; August 1, 2004.

  32. Koppen, S.; De Groot, R.; Neijens, H. J.; Nagelkerke, N.; Van Eden, W.; Rumke, H. C.  No Epidemiological Evidence for Infant Vaccinations to Cause Allergic Disease.   Vaccine.  22 (25-26): 3375-3385; September 3, 2004.

  33. Kumagai, T.; Nagai, K.; Okui, T.; Tsutsumi, H.; Nagata, N.; Yano, S.; Nakayama, T.; Okuno, Y.; Kamiya, H.  Poor Immune Responses to Influenza Vaccination in Infants.   Vaccine.  22 (25-26): 3404-3410; September 3, 2004.

  34. Lackmann, G. M.  Comparative Investigation of the Safety of Hexavalent Vaccines for Primary Scheduled Infant Immunizations in Germany Over a Time Period of 2 Years.   Med.Sci.Monit.  10 (9): PI96-PI98; August, 2004. [Epub ahead of print].

  35. Leissner, K. B.; Holzman, R. S.; McCann, M. E.  Bioterrorism and Children; Unique Concerns With Infection Control and Vaccination.   Anesthesiol.Clin.North America.  22 (3): 563-577; September, 2004.

  36. Levitt, C.; Shaw, E.; Wong, S.; Kaczorowski, J.; Springate, R.; Sellors, J.; Enkin, M.  Systematic Review of the Literature on Postpartum Care: Selected Contraception Methods, Postpartum Papanicolaou Test, and Rubella Immunization.   Birth.  31 (3): 203-212; September, 2004.

  37. Levy, C.; Carter, S.; Priloutskaya, G.; Gallegos, G.   Critical Elements in the Design of Culturally Appropriate Interventions Intended to Reduce Health Disparities: Immunization Rates Among Hispanic Seniors in New Mexico.   J.Health Hum.Serv.Adm.  26 (2): 199-238; 2003.

  38. Lindberg, A.  [Vaccinations--Primary Prevention With Problems].   Lakartidningen.  101 (28-29): 2352-2354; July 8, 2004.

  39. McVernon, J.; Howard, A. J.; Slack, M. P.; Ramsay, M. E.  Long-Term Impact of Vaccination on Haemophilus Influenzae Type b (Hib) Carriage in the United Kingdom.   Epidemiol.Infect.  132 (4): 765-767; August, 2004.

  40. Mommers, M.; Weishoff-Houben, M.; Swaen, G. M.; Creemers, H.; Freund, H.; Dott, W.; Van Schayck, C. P.  Infant Immunization and the Occurrence of Atopic Disease in Dutch and German Children: A Nested Case-Control Study.   Pediatr.Pulmonol.  38 (4): 329-334; October, 2004.

  41. Nowalk, M. P.; Zimmerman, R. K.; Feghali, J.  Missed Opportunities for Adult Immunization in Diverse Primary Care Office Settings.   Vaccine.  22 (25-26): 3457-3463; September 3, 2004.

  42. Papadimitropoulos, V.; Vergidis, P. I.; Bliziotis, I.; Falagas, M. E.  Vaccination Against Typhoid Fever in Travellers: a Cost-Effectiveness Approach.   Clin.Microbiol.Infect.  10 (8): 681-683; August, 2004.

  43. Pena-Rey, I.; Perez-Farinos, N.; Cortes-Garcia, M.; Amela-Heras, C.  [Cost-Effectiveness of Varicella Vaccination in Spanish Adolescents].   Gac.Sanit.  18 (4): 287-294; July, 2004.

  44. Porco, T. C.; Holbrook, K.; Fernyak, S. E.; Portnoy, D.; Reiter, R.; Aragon, T. J.  Logistics of Smallpox Control Through Ring Vaccination: a Stochastic Network Model.   BMC.Public Health.  4 (1): 34; August 6, 2004.

  45. Puricelli, R. C.; Kupek, E.; Bertoncini, Rde C.  [Control of a Community Outbreak of Group C Meningococcal Meningitis in Corupa, Santa Catarina State, Brazil, Based on Rapid and Effective Epidemiological Surveillance and Immunization].   Cad.Saude Publica.  20 (4): 959-967; July, 2004.

  46. Schattenfroh, C.  [Acute Disseminated Encephalomyelitis After Immunization Against Tick-Borne Encephalitis].   Nervenarzt.  75 (8): 776-779; August, 2004.

  47. Schwab, J.; Ryan, M.  Varicella Zoster Virus Meningitis in a Previously Immunized Child.   Pediatrics.  114 (2): e273-e274; August, 2004.

  48. Stipic-Markovic, A.; Pevec, B.; Radulovic, Pevec M.; Custovic, A.; Predovic, J.  Allergic Diseases in Relationship With Environmental Factors in a Population of School Children in Zagreb, Croatia.   Arh.Hig.Rada Toksikol.  55 (2-3): 221-228; June, 2004.

  49. Tacken, M. A.; Braspenning, J. C.; Berende, A.; Hak, E.; De Bakker, D. H.; Groenewegen, P. P.; Grol, R. P.  Vaccination of High-Risk Patients Against Influenza: Impact on Primary Care Contact Rates During Epidemics; Analysis of Routinely Collected Data.   Vaccine.  22 (23-24): 2985-2992; August 13, 2004.

  50. Thiry, N.; Beutels, P.; Tancredi, F.; Romano, L.; Zanetti, A.; Bonanni, P.; Gabutti, G.; Damme, P. V.  An Economic Evaluation of Varicella Vaccination in Italian Adolescents.   Vaccine.  22 (27-28): 3546-3562; September 9, 2004.

  51. Uzicanin, A.; Zhou, F.; Eggers, R.; Webb, E.; Strebel, P.  Economic Analysis of the 1996-1997 Mass Measles Immunization Campaigns in South Africa.   Vaccine.  22 (25-26): 3419-3426; September 3, 2004.

  52. Young, D. C.; Bleyl, K.; Clark, T.; Oderda, G.; Liou, T. G.  Increasing Pneumococcal Vaccination Rates Among Adults With Cystic Fibrosis.   Am.J.Health Syst.Pharm.  61 (14): 1490-1493; July 15, 2004.

[Top]